Ig VENA 50 g/L | Solution for Infusion | 5 g in 100 mL In Pakistan

In Stock
Rs 125000

Looking To Buy Original Ig VENA 50 g/L | Solution for Infusion | 5 g in 100 mL In Pakistan? We Have It At Best Price In Pakistan. Order Now And Get It At Your Home. Get The Best Deals On Ig VENA 50 g/L | Solution for Infusion | 5 g in 100 mL In Pakistan From topmalll.com. Ig VENA 50 g/L | Solution for Infusion | 5 g in 100 mL In Pakistan Offers Online In Karachi, Lahore, Islamabad & All Across Pakistan. Cash On Delivery.Read more

Product Condition: Sealed By no means open, By no means used
Category: Other Products
Payment Mode: Cash On Delivery, Bank Transfer
Delivery Time: 1 To 2 Days

Latest Reviews

Comment author

Hira khan

Verified Purchase Oct-03-2026

Smooth ordering experience and timely delivery mil gii

Ig VENA 50 g/L | Solution for Infusion | 5 g in 100 mL In Pakistan - Topmalll.com

Ig VENA 50 g/L is a human normal immunoglobulin (IVIg) solution containing 50 mg/mL of immunoglobulin, with at least 95% IgG. The 100 mL vial contains 5 g of human normal immunoglobulin and is administered intravenously. It is used as replacement therapy in certain antibody deficiencies and as immunomodulatory treatment for selected immune-related conditions.

Specifications:

  • Brand: Ig VENA
  • Active Ingredient: Human Normal Immunoglobulin (IVIg)
  • Strength: 50 g/L (5%)
  • Presentation: 5 g in 100 mL
  • Dosage Form: Solution for infusion
  • Route: Intravenous (IV)
  • IgG Content: At least 95%
  • Manufacturer: Kedrion S.p.A., Italy

Benefits:

Ig VENA provides antibodies to patients who have inadequate antibody production and may help reduce recurrent bacterial infections in appropriately selected patients. IVIg can also have an immunomodulatory effect and is used in conditions such as immune thrombocytopenia (ITP), Guillain-Barré syndrome, CIDP, and Kawasaki disease, depending on the approved indication and physician's assessment.

How to Use:

Ig VENA must be administered by intravenous infusion under medical supervision. The dose and treatment schedule are individualized according to the patient's condition, body weight, clinical response, and the specific indication. The infusion is generally started slowly and increased gradually if well tolerated. Patients should be monitored for infusion reactions and other potential complications.

You May Also Like